hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06286618, orgStudyIdInfo id: HHSN268201800015I, briefTitle: Nutrition360: Moving to Integrated and Holistic Disease Prevention Among Underserved Mississippians, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2022-09-01, primaryCompletionDateStruct date: 2024-08-31, completionDateStruct date: 2024-08-31, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-02-29, sponsorCollaboratorsModule leadSponsor name: University of Southern Mississippi, class: OTHER, collaborators name: My Brother's Keeper, descriptionModule briefSummary: The objective for the study is to implement a pilot study to establish essential components to address diet quality in healthcare settings and examine what value an integrated service model delivery has for the primary prevention of cardiometabolic diseases with an initial focus on dietary behaviors. This objective will be met by 1: Utilizing a multiphase optimization study design to select and optimize essential components to address diet behaviors and 2: Comparing an integrated and referral-based delivery model for healthcare-based strategies that address structural and psychosocial barriers to a healthy diet for racial/ethnic minority, marginalized and disadvantaged background young to middle aged adult populations in Mississippi., conditionsModule conditions: Cardiovascular Diseases, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: DOUBLE, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 24, type: ACTUAL, armsInterventionsModule interventions name: Psychosocial Intervention, interventions name: Structural Intervention, interventions name: Traditional Psychosocial+Structural, interventions name: Integrated Psychosocial+Structural, outcomesModule primaryOutcomes measure: Participant Burden, secondaryOutcomes measure: Diet Quality, secondaryOutcomes measure: cost effectiveness, eligibilityModule sex: ALL, minimumAge: 25 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule locations facility: The University of Southern Mississippi, city: Hattiesburg, state: Mississippi, zip: 39406-0001, country: United States, geoPoint lat: 31.32712, lon: -89.29034, hasResults: False
protocolSection identificationModule nctId: NCT06286605, orgStudyIdInfo id: UNISS_PHD_Osstem_4, briefTitle: RCT GBR One Stages Comparing A-Oss and Autogenous Bone Versus A-Oss and LCR-A, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-12-30, completionDateStruct date: 2028-12-30, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-02-29, sponsorCollaboratorsModule leadSponsor name: Università degli Studi di Sassari, class: OTHER, collaborators name: Dr. Dario Melodia, collaborators name: Dr. Milena Pisano, collaborators name: Dr. Aurea Lumbau, collaborators name: Prof. Silvio Mario Meloni, collaborators name: Prof. Edoardo Baldoni, descriptionModule briefSummary: The aim of this randomized controlled trial is to evaluate the tridimensional bone stability after horizontal one-stage GBR using collagene membrane (OssMem) with a mix of Bovine Bone Substitute (A-Oss) and autogenous bone (test group) versus A-Oss and LCR-A, a synthetic bone (control group)., conditionsModule conditions: Guided Bone Regeneration, conditions: Dental Implant, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Multicenter, randomized controlled trial of parallel-group design., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 42, type: ESTIMATED, armsInterventionsModule interventions name: A-oss and autogenous bone, interventions name: A-oss an LCR-A, outcomesModule primaryOutcomes measure: Rate of Implants survival, primaryOutcomes measure: Number of Participants with prosthesis failure, primaryOutcomes measure: Number of complications, secondaryOutcomes measure: Horizontal and volumetric dimensional changes, secondaryOutcomes measure: Rate of peri-implant marginal bone level, secondaryOutcomes measure: Plaque Index and bleeping on probing, secondaryOutcomes measure: Valuation of patient satisfaction, secondaryOutcomes measure: Valuation of soft tissue thickness and amount of keratinized tissue, secondaryOutcomes measure: Rate of pes score, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Marco Tallarico, city: Sassari, zip: 07100, country: Italy, contacts name: Dario Melodia, Dr, role: CONTACT, phone: 3331226618, email: dariomld1@gmail.com, contacts name: Marco Tallarico, Prof, role: CONTACT, phone: 3280758769, email: me@studiomarcotallarico.it, geoPoint lat: 40.72586, lon: 8.55552, hasResults: False
protocolSection identificationModule nctId: NCT06286592, orgStudyIdInfo id: Pro2023002053, briefTitle: LUNGevity: Lung Cancer Stigma Community Based Participatory Research, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2025-11, completionDateStruct date: 2025-11, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-03-29, sponsorCollaboratorsModule leadSponsor name: Rutgers, The State University of New Jersey, class: OTHER, descriptionModule briefSummary: Lung cancer survival rates are low for intersectional underserved groups. Lung cancer stigma and intersectional stigma related to minoritized group status leads to increased morbidity and mortality and health disparities. Mindfulness interventions have been shown to decrease stigma and the negative impacts of stigma, however, these interventions have never been tested to decrease lung cancer stigma specifically. In this study, the investigators will use Community Based Participatory Research framework and MOST methodology to build and optimize a brief virtual mindfulness intervention to decrease lung cancer stigma, through first building a diverse coalition of lung cancer patients on a participatory action council., conditionsModule conditions: Lung Cancer, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: FACTORIAL, interventionModelDescription: Details of the specific interventions will be selected in collaboration with the Community Advisory Board.Then, in a Phase IB trial, we will use a MOST design to assign patients to promising intervention components, combining them and altering exposure time, measuring preliminary effects of possible components of interventions. Details of the specific interventions will be selected in collaboration with the Community Advisory Board., primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Ultra-brief mindfulness intervention video, interventions name: Forgiveness video, interventions name: ACT values video, outcomesModule primaryOutcomes measure: Lung Cancer Stigma Inventory (LCSI), primaryOutcomes measure: Tobacco use quit likelihood, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06286579, orgStudyIdInfo id: UNISS_PHD_Osstem_3, briefTitle: SOI Immediately vs Delayed, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2028-01-31, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-02-29, sponsorCollaboratorsModule leadSponsor name: Università degli Studi di Sassari, class: OTHER, collaborators name: Dr. Dario Melodia, collaborators name: Dr. Milena Pisano, collaborators name: Dr. Aurea M. I. Lumbau, collaborators name: Prof. Silvio Mario Meloni, collaborators name: Prof. Edoardo Baldoni, descriptionModule briefSummary: The aim of this randomized controlled trial is to compare the clinical and radiographic of immediately loaded, immediate (post-extractive, test group) versus delayed (control group) implants with new SOI surface, conditionsModule conditions: Dental Implant, conditions: Dental Implant-Abutment Design, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomised controlled trial of parallel group design., primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, maskingDescription: One "blinded (when possible)" independent assessor, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 70, type: ESTIMATED, armsInterventionsModule interventions name: Immediately implant placement, interventions name: Delayed, outcomesModule primaryOutcomes measure: Number of prosthesis failure, primaryOutcomes measure: Number of implant failure, primaryOutcomes measure: Number of complications, secondaryOutcomes measure: Rate of peri-implant marginal bone level changes, secondaryOutcomes measure: Valuation of patient satisfaction, secondaryOutcomes measure: Rate of implant stability quotient (ISQ), secondaryOutcomes measure: Valuation of soft tissue thickness and amount of keratinized tissue, secondaryOutcomes measure: Number of PES score, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Marco Tallarico, city: Sassari, zip: 07100, country: Italy, geoPoint lat: 40.72586, lon: 8.55552, hasResults: False
protocolSection identificationModule nctId: NCT06286566, orgStudyIdInfo id: UNISS_PHD_Osstem_2, briefTitle: Soi TS3 Surface in Patients With and Without Type 2 Diabetes, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2024-12-31, completionDateStruct date: 2028-01-31, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-02-29, sponsorCollaboratorsModule leadSponsor name: Università degli Studi di Sassari, class: OTHER, collaborators name: Dr. Dario Melodia, collaborators name: Dr. Milena Pisano, collaborators name: Dr. Aurea M. I. Lumbau, collaborators name: Prof. Silvio Mario Meloni, collaborators name: Prof. Edoardo Baldoni, descriptionModule briefSummary: The aim of this prospective cohort study is to compare clinical and radiographic data of Osstem implants with SOI surface placed in patients with or without diabetes., conditionsModule conditions: Dental Implant, conditions: Dental Implant-Abutment Design, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Multicenter prospective cohort study, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, maskingDescription: centralized radiographic assessor, outcome assessors(when possible), and the statistical advisors will be blind to the used implants, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 84, type: ESTIMATED, armsInterventionsModule interventions name: Implant placement with soi surface in diabetic subjects, interventions name: Implant placement with soi surface in healthy subjects, outcomesModule primaryOutcomes measure: Number of prosthesis failure:, primaryOutcomes measure: Number of implant failure, primaryOutcomes measure: Number of complication, secondaryOutcomes measure: Rate of peri-implant marginal bone level changes, secondaryOutcomes measure: Valuation of patient satisfaction, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Marco Tallarico, city: Rome, state: Sassari, zip: 07100, country: Italy, geoPoint lat: 41.89193, lon: 12.51133, hasResults: False
protocolSection identificationModule nctId: NCT06286527, orgStudyIdInfo id: EssaiClinique_PREP-QUAL-VS, briefTitle: Quality of Sexual Life of PrEP Users, acronym: PREP-QUAL-VS, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-06, primaryCompletionDateStruct date: 2024-09-06, completionDateStruct date: 2024-09-06, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-03-01, sponsorCollaboratorsModule leadSponsor name: University Hospital, Grenoble, class: OTHER, descriptionModule briefSummary: The study will recruit participants on the occasion of their visit in a sexual health center or another HIV pre-exposure prophylaxis (PrEP) facility in France.PrEP users will be proposed to fill a self-administered, online, anonymous questionnaire regarding how they perceive different fields of their sexual life, and how they perceive that PrEP has an impact on the quality of sexual life., conditionsModule conditions: HIV Pre-exposure Prophylaxis Use, conditions: Adult, designModule studyType: OBSERVATIONAL, designInfo observationalModel: OTHER, timePerspective: OTHER, enrollmentInfo count: 1000, type: ESTIMATED, armsInterventionsModule interventions name: anonymous self-administered online questionnaire, outcomesModule primaryOutcomes measure: quality of sexual life as assessed by a set of questions, primaryOutcomes measure: perceived influence of PrEP use on the quality of sexual life, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Olivier EPAULARD, city: Grenoble, state: Is, zip: 38043, country: France, contacts name: Olivier EPAULARD, MD, PhD, role: CONTACT, phone: +33476765291, email: oepaulard@chu-grenoble.fr, geoPoint lat: 45.16667, lon: 5.71667, hasResults: False
protocolSection identificationModule nctId: NCT06286514, orgStudyIdInfo id: STUDY00019996, briefTitle: Food at Home Study, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-01, primaryCompletionDateStruct date: 2026-03-30, completionDateStruct date: 2026-03-30, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-04-16, sponsorCollaboratorsModule leadSponsor name: University of Minnesota, class: OTHER, descriptionModule briefSummary: The study objective is to develop an accessible home food environment assessment toolkit that includes valid and reliable paper and electronic tools targeting foods known to impact diet-related health that can be user-administered across literacy levels in English and Spanish., conditionsModule conditions: Obesity, conditions: Diet, Healthy, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 350, type: ESTIMATED, armsInterventionsModule interventions name: No intervention, outcomesModule primaryOutcomes measure: Usability of HFI core, primaryOutcomes measure: Acceptability of HFI core, primaryOutcomes measure: Concurrent criterion validity of HFI core, primaryOutcomes measure: Concurrent criterion validity of HFI core, primaryOutcomes measure: Convergent construct validity of HFI core, primaryOutcomes measure: Convergent construct validity of HFI core, primaryOutcomes measure: Test-retest reliability of HFI core, primaryOutcomes measure: Usability of eHFI, primaryOutcomes measure: Acceptability of eHFI, primaryOutcomes measure: Concurrent criterion validity of eHFI, primaryOutcomes measure: Concurrent criterion validity of eHFI, primaryOutcomes measure: Convergent construct validity of eHFI, primaryOutcomes measure: Convergent construct validity of eHFI, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 99 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: University of Minnesota, status: RECRUITING, city: Minneapolis, state: Minnesota, zip: 55414, country: United States, contacts name: Sarah Friend, role: CONTACT, geoPoint lat: 44.97997, lon: -93.26384, hasResults: False
protocolSection identificationModule nctId: NCT06286488, orgStudyIdInfo id: KB/96/2020, briefTitle: Effectiveness and Tolerability of Influenza Vaccine in Patients at Risk for Severe and Complicated Influenza, statusModule overallStatus: ACTIVE_NOT_RECRUITING, startDateStruct date: 2020-09-15, primaryCompletionDateStruct date: 2023-08-23, completionDateStruct date: 2026-05-01, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-03-01, sponsorCollaboratorsModule leadSponsor name: Medical University of Warsaw, class: OTHER, descriptionModule briefSummary: The aim of the study is to evaluate simultaneously the immunological and clinical efficacy and tolerability of an influenza vaccine, inactivated, quadrivalent, with cleaved virus, in patients at risk for severe and complicated influenza routinely vaccinated against influenza in family medicine clinics or specialty clinics (pediatric, internal medicine, cardiology, gynecological diabetes, pregnant women, transplant)., conditionsModule conditions: Influenza, conditions: Obesity, conditions: Pregnancy; Infection, conditions: Elderly Infection, conditions: Vaccine Reaction, conditions: Vaccine Adverse Reaction, conditions: Tolerance, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: NON_RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: PREVENTION, maskingInfo masking: NONE, enrollmentInfo count: 1500, type: ACTUAL, armsInterventionsModule interventions name: Vaxigrip, outcomesModule primaryOutcomes measure: influenza vaccine immunogenicity, seroconversion and seroprotection, secondaryOutcomes measure: assessment of vaccination tolerance, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 99 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Department of Social Medicine and Public Health, Medical University of Warsaw, city: Warsaw, zip: 02-077, country: Poland, geoPoint lat: 52.22977, lon: 21.01178, hasResults: False
protocolSection identificationModule nctId: NCT06286475, orgStudyIdInfo id: VGCS-50635-003, briefTitle: A Study of VRG50635 in Healthy Volunteers, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-29, primaryCompletionDateStruct date: 2024-05, completionDateStruct date: 2024-05, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-03-27, sponsorCollaboratorsModule leadSponsor name: Verge Genomics, class: INDUSTRY, descriptionModule briefSummary: The primary objectives of this study are to investigate the safety and tolerability of VRG50635 and to determine how VRG50635 is absorbed by the body., conditionsModule conditions: Healthy Volunteers, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: SEQUENTIAL, interventionModelDescription: This is a 2-part study that includes both an open-label (Part 1) and a double-blind, placebo-controlled (Part 2) design. In Part 1, participants will be randomly assigned to receive open-label VRG50635 in 1 of 2 treatment sequences. In Part 2, participants will receive VRG50635 or placebo in a double-blind manner., primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: VRG50635, interventions name: Placebo, outcomesModule primaryOutcomes measure: Number of Participants with Adverse Events, primaryOutcomes measure: Area Under the Concentration-time Curve from Time 0 Extrapolated to Infinity (AUCinf), primaryOutcomes measure: Area Under the Concentration-time Curve from Time 0 to the Last Measurable Concentration (AUClast), primaryOutcomes measure: Area Under the Concentration-time Curve from Time 0 to 24 Hours Post-dose (AUC0-24), primaryOutcomes measure: Area Under the Concentration-time Curve Between Consecutive Doses (AUCtau), primaryOutcomes measure: Maximum Observed Concentration (Cmax), primaryOutcomes measure: Half-life (t1/2), primaryOutcomes measure: Time of Maximal Plasma Concentration (tmax), eligibilityModule sex: ALL, minimumAge: 19 Years, maximumAge: 55 Years, stdAges: ADULT, contactsLocationsModule locations facility: Site 001, status: RECRUITING, city: Lincoln, state: Nebraska, zip: 68502, country: United States, geoPoint lat: 40.8, lon: -96.66696, hasResults: False
protocolSection identificationModule nctId: NCT06286436, orgStudyIdInfo id: IR.SBMU.RETECH.REC.1401.842, briefTitle: Effect of Dual-task Training on the Number of EEG Band in Stroke Patients, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-02-25, primaryCompletionDateStruct date: 2024-04-29, completionDateStruct date: 2024-05-29, studyFirstPostDateStruct date: 2024-02-29, lastUpdatePostDateStruct date: 2024-03-01, sponsorCollaboratorsModule leadSponsor name: Universidad de Zaragoza, class: OTHER, descriptionModule briefSummary: Stroke is a prevalent global health concern, causing widespread disability as it disrupts blood supply to the brain, leading to functional impairments. Upper limb dysfunction affects over 80% of stroke survivors acutely and becomes permanent in approximately 60%, hindering daily activities and autonomy. Dual-task training (DTT), involving simultaneous cognitive and motor tasks resembling daily activities, is proposed as an effective intervention.The study suggests using electroencephalogram (EEG) analysis, particularly the Fast Fourier Transform (FFT), to assess changes in brain signals pre- and post-DTT intervention. EEG provides real-time insights into brain function, and FFT analyzes signal frequencies. The intervention involves three tasks performed concurrently with mental calculations, such as sorting blocks and manipulating objects. This 12-session, four-week intervention aims to improve upper limb function. The study explores EEG's role in evaluating DTT effects on stroke patients, particularly using FFT to analyze brain signal frequencies., conditionsModule conditions: Stroke, conditions: Electroencephalography, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 5, type: ESTIMATED, armsInterventionsModule interventions name: Dual-task training, outcomesModule primaryOutcomes measure: EEG Data, secondaryOutcomes measure: Upper limb function, secondaryOutcomes measure: Elbow flexor muscle tone, secondaryOutcomes measure: Wrist extension range of motion, secondaryOutcomes measure: ADLs, eligibilityModule sex: FEMALE, minimumAge: 35 Years, maximumAge: 75 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Shahid Beheshti University of Medical Sciences, city: Tehran, state: Velenjak, country: Iran, Islamic Republic of, contacts name: Borhan Asadi, Eng, role: CONTACT, geoPoint lat: 35.69439, lon: 51.42151, hasResults: False